MedTrace Logo

Virtual Reality Cognitive Therapy for Alzheimer's Disease

NCT05788848 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2024-12-30

No results posted yet for this study

Summary

To evaluate the usability, feasibility, and acceptability of VRCT iteratively on 36 AD/ADRD individuals with mild to moderate CI.

Conditions

  • Alzheimer Disease

Interventions

BEHAVIORAL

VRCT

The VRCT will focus primarily on skills that impact instrumental activities of daily living (e.g., taking medications, shopping). Thirty-six individuals with mild to moderate AD/ADRD will be enrolled and will utilize the VRCT over seven weeks within their home.

Sponsors & Collaborators

  • HealthPartners Institute

    collaborator OTHER

  • Claritytek, Inc.

    lead INDUSTRY

Principal Investigators

  • Leah R Hanson, PhD · HealthPartners Neuroscience Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-31
Primary Completion
2024-08-20
Completion
2024-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05788848 on ClinicalTrials.gov